HRTX Earnings Date 2026
Heron Therapeuti earnings schedule and quarterly results
Next Earnings Date
TBD
Current Stock Price
$0.31
-1.06% today
Earnings Metrics
EPS (TTM)
$-0.09
P/E Ratio
-3.5
Revenue Growth
16.5%
Market Cap
$0.3B
Earnings History
| Quarter | EPS | Revenue | Net Income |
|---|---|---|---|
| Q4 2024 | $-0.09 | - | $-0.01B |
| Q4 2023 | $-0.80 | - | $-0.11B |
Trading Around HRTX Earnings
Before Earnings
- Review analyst expectations and consensus estimates
- Check options implied volatility for expected move
- Consider historical earnings surprises
- Monitor pre-announcement guidance
After Earnings
- Compare actual results to estimates
- Listen to the earnings call for guidance
- Watch for analyst rating changes
- Monitor institutional buying/selling
Get Full HRTX Analysis
DCF valuation, AI insights, and institutional ownership data
Frequently Asked Questions
When is HRTX next earnings date?
HRTX (Heron Therapeuti) has not yet announced its next earnings date. Check back for updates on the upcoming earnings schedule.
What is HRTX earnings per share (EPS)?
HRTX's current earnings per share (EPS) is $-0.09. With a P/E ratio of -3.5, the market values each dollar of earnings at $-3.5.
How often does HRTX report earnings?
Like most publicly traded US companies, HRTX (Heron Therapeuti) reports earnings quarterly, typically within 4-6 weeks after each fiscal quarter ends. The company holds an earnings call to discuss results with analysts.
What time does HRTX report earnings?
HRTX typically reports earnings either before market open (BMO) or after market close (AMC). The exact time is usually announced a few days before the earnings date. Check the investor relations page for specific timing.
How has HRTX performed in recent earnings?
In the most recent quarter (Q4 2024), HRTX reported EPS of $-0.09.
What do analysts expect for HRTX earnings?
Analyst expectations for HRTX earnings can vary. The company has shown positive revenue growth of 16.5%. View the full analyst ratings page for detailed expectations.